BioCina
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
8 Dalgleish St, Thebarton, South Austral...Phone Number
+61 881508200Website
www.biocina.comRevenue
$9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About BioCina
BioCina is a global contract development and manufacturing organization (CDMO) specializing in biologics, offering end-to-end services from process development to cGMP manufacturing. The company provides a range of drug product and substance offerings, including microbial, plasmid DNA, mRNA, and lipid nanoparticles, ensuring high-quality and timely delivery. BioCina's clients include pharmaceutical and biotechnology companies looking to accelerate their therapies to market. With facilities in Adelaide and Perth, BioCina is the only biologics CDMO in Australia approved by the US FDA, emphasizing its commitment to quality and compliance.Explore more
BioCina Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioCina your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BioCina recently announced quarterly report
Check if BioCina has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BioCina launches new products
Click to see if BioCina had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at BioCina
BioCina, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioCina is spiking on competitors!
Funding: Get notified immidiatlly once BioCina has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to BioCina
Compare insights from companies similar to BioCina, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioCina is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioCina is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioCina.
BioCina Tech Stack
A closer look at the technologies used by BioCina
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Open Position
BioCina News & Media
BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer
SAN DIEGO and PERTH, Australia and ADELAIDE, Australia, Oct. 28, 2025 /PRNewswire/ -- BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as Chief Executive Officer to lead the company's...BioCina and NovaCina Merger Bolsters Global CDMO Industry
ADELAIDE, South Australia and PERTH, Western Australia, Jan. 14, 2025 /PRNewswire/ -- Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand in biopharmaceutical and small molecule contract manufacturing. The combined company, which will retain the BioCina name, will be fully integrated to provide the market a seamless, end-to-end offering, from cell line development and process development, to cliniCentivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax, Inc., for a project involving cell line development, cell banking and plasmid DNA manufacture. Centivax is developing Cent-Flu, a universal influenza vaccine, consisting of a proprietary multivalent mixture of 22 unique mRNA transcripts delivered as a lipid nanoparticle (LNP) encapsulated mRNEnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment
ADELAIDE, South Australia, Sept. 24, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug developer EnGeneIC Pty Ltd., for a project including technology transfer, process...
Read more news
Top Chemicals & Related Products Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BioCina
Sign Up For FreeTo access detailed company insights
BioCina is a global contract development and manufacturing organization (CDMO) specializing in biologics, offering end-to-end services from process development to cGMP manufacturing. The company provides a range of drug product and substance offerings, including microbial, plasmid DNA, mRNA, and lipid nanoparticles, ensuring high-quality and timely... Read More
